Cargando…

Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification

BACKGROUND: The hepatic resection for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) which is not uncommon at clinic continues to be debated. Our study introduced a novel classification of HCC with PVTT and compared the outcomes of surgical treatment between different groups....

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiang-feng, Liu, Xi-yu, Wang, Shuai, Wen, Huai-xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352541/
https://www.ncbi.nlm.nih.gov/pubmed/25889711
http://dx.doi.org/10.1186/s12957-015-0493-x
_version_ 1782360476879945728
author Xu, Jiang-feng
Liu, Xi-yu
Wang, Shuai
Wen, Huai-xi
author_facet Xu, Jiang-feng
Liu, Xi-yu
Wang, Shuai
Wen, Huai-xi
author_sort Xu, Jiang-feng
collection PubMed
description BACKGROUND: The hepatic resection for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) which is not uncommon at clinic continues to be debated. Our study introduced a novel classification of HCC with PVTT and compared the outcomes of surgical treatment between different groups. METHODS: From January 2008 to December 2012, a total of 56 cases of HCC with PVTT underwent liver resection combined with thrombectomy. Clinical pathological features and surgical data of these patients were retrospectively studied. The patients were divided into two groups. Cumulative overall and disease-free survival curves of the patients were compared according to different groups. RESULTS: Sixteen patients (28.6%) belonging to group A were compared to 40 patients (71.4%) belonging to group B. The rates of capsular formation and tumor number showed differences between the two groups (P = 0.047, P = 0.032). Group A had more liver cirrhosis than group B (P = 0.047). The patients with large blood loss (≥1,000) were more in group A, as well. There was no significant difference in complications between the two groups except the ascites (P = 0.028). The 1-year overall survival rate of group A after liver resection was 31.5%. The 1-, 3-, and 5-year overall survival rates of group B were 62.3%, 16.1%, and 5.2%, respectively. For further study, group B had significantly better overall survival than group A (P = 0.033). Group A had significantly higher incidence of recurrence than group B (P = 0.021). CONCLUSIONS: Liver resection combined with thrombectomy for HCC with PVTT can get better outcome in the HCC patients with PVTT involving only one branch (left/right) of portal vein (group B) compared to patients with PVTT involving the main portal vein trunk or both the left and right portal veins (group A). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12957-015-0493-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4352541
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43525412015-03-09 Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification Xu, Jiang-feng Liu, Xi-yu Wang, Shuai Wen, Huai-xi World J Surg Oncol Research BACKGROUND: The hepatic resection for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) which is not uncommon at clinic continues to be debated. Our study introduced a novel classification of HCC with PVTT and compared the outcomes of surgical treatment between different groups. METHODS: From January 2008 to December 2012, a total of 56 cases of HCC with PVTT underwent liver resection combined with thrombectomy. Clinical pathological features and surgical data of these patients were retrospectively studied. The patients were divided into two groups. Cumulative overall and disease-free survival curves of the patients were compared according to different groups. RESULTS: Sixteen patients (28.6%) belonging to group A were compared to 40 patients (71.4%) belonging to group B. The rates of capsular formation and tumor number showed differences between the two groups (P = 0.047, P = 0.032). Group A had more liver cirrhosis than group B (P = 0.047). The patients with large blood loss (≥1,000) were more in group A, as well. There was no significant difference in complications between the two groups except the ascites (P = 0.028). The 1-year overall survival rate of group A after liver resection was 31.5%. The 1-, 3-, and 5-year overall survival rates of group B were 62.3%, 16.1%, and 5.2%, respectively. For further study, group B had significantly better overall survival than group A (P = 0.033). Group A had significantly higher incidence of recurrence than group B (P = 0.021). CONCLUSIONS: Liver resection combined with thrombectomy for HCC with PVTT can get better outcome in the HCC patients with PVTT involving only one branch (left/right) of portal vein (group B) compared to patients with PVTT involving the main portal vein trunk or both the left and right portal veins (group A). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12957-015-0493-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-28 /pmc/articles/PMC4352541/ /pubmed/25889711 http://dx.doi.org/10.1186/s12957-015-0493-x Text en © Xu et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Xu, Jiang-feng
Liu, Xi-yu
Wang, Shuai
Wen, Huai-xi
Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification
title Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification
title_full Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification
title_fullStr Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification
title_full_unstemmed Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification
title_short Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification
title_sort surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352541/
https://www.ncbi.nlm.nih.gov/pubmed/25889711
http://dx.doi.org/10.1186/s12957-015-0493-x
work_keys_str_mv AT xujiangfeng surgicaltreatmentforhepatocellularcarcinomawithportalveintumorthrombusanovelclassification
AT liuxiyu surgicaltreatmentforhepatocellularcarcinomawithportalveintumorthrombusanovelclassification
AT wangshuai surgicaltreatmentforhepatocellularcarcinomawithportalveintumorthrombusanovelclassification
AT wenhuaixi surgicaltreatmentforhepatocellularcarcinomawithportalveintumorthrombusanovelclassification